KDM1A and cancer: In addition, other LSD1-specific inhibitors such as ORY-2001, IMG-7289, GSK2879552, and ORY-1001, can target LSD1 with more potency, compared to TCP and they may be useful for other cancer type treatments, such as acute myeloid leukaemia [67].